After a years-long battle between the Sackler family and the Department of Justice, as well as a Netflix (NASDAQ:NFLX) series ...

Purdue Pharma has won support from the attorneys general of 55 U.S. states and territories for its $7.4 billion settlement to ...

Arkansas will receive $44.5 million annually for 17 years as part of a settlement with Purdue Pharma and the Sackler family, with one-third of the funds allocated to the state and the remaining ...

The Sackler family will now relinquish control of Purdue Pharma and cease sale of opioids in the U.S. as part of a $7.4 billion settlement.

Purdue Pharma announced its settlement with all 55 attorneys general on Monday after longstanding allegations.

Purdue Pharma and Sackler family members who own the company have reached a $7.4 billion settlement with all 50 states and U.S. territories over the company's improper marketing of opioids.

All 50 states agreed Monday to sign a settlement with Purdue Pharma, the company behind the highly addictive opioid Oxycontin, accepting $7.4 billion in payouts and prohibiting the Sackler family ...

A $7.4 billion settlement with Purdue Pharma and its owners, the Sackler family, was agreed to be signed by 55 attorneys general representing states and United States territories, Attorney General ...

The deal would be among the largest in a wave of opioid settlements. It calls for members of the Sackler family who own the company to give up ownership and to contribute up to $7 billion over time.

Purdue Pharma and Sackler family members who own the company have reached a $7.4 billion settlement with all 50 states and U.S. territories over the company's improper marketing of opioids.

Purdue Pharma and Sackler family members who own the company have reached a $7.4 billion settlement with all 50 states and U.S. territories over the company's improper marketing of opioids.